CerebrolysinCBL60

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Cognitive & Neuro Research

Cerebrolysin

Post-stroke neurological and functional rehabilitation

Cerebrolysin specifications and reference prices. Select a specification to add it to your cart.

60mg/vial x 10vials

Reference priceUS$152.94

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
CBL6060mg/vial x 10vialsUS$152.94

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related data on post-stroke neurological and functional rehabilitation of Cerebrolysin. First, look at the research questions and findings, then check the population or species, study formulations, and scope of interpretation.

Main TopicsPost-stroke neurological · functional rehabilitation
USAGE REFERENCE

Cerebrolysin · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
ReferenceMainly injection; neurorehabilitation study

🔁Cycle

According to research protocol.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist regarding Cerebrolysin in post-stroke neurological and functional rehabilitation?

Adjunct Cerebrolysin associated with better 12-month functional independence. Additional research reports: adding Cerebrolysin associated with improvement in 14-day neurological and daily living ability scores.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 main theme articles · Identity/formulation needs verificationSorted by First Publication Date ↓
Human Study2026REF. 01

How should functional follow-up be interpreted for stroke populations after thrombus removal?

Research Findings

Adjunct Cerebrolysin associated with better 12-month functional independence.[1] ↗

Study Design

Propensity-matched observational cohort of stroke thrombectomy patients

Scope & Limitations

Selective population, no random assignment, residual confounding exists.

View the Article Title and Full Citation+

Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.

Staszewski J, Dębiec A, Gniadek-Olejniczak K, Stępień A, Piusinska-Macoch R, Strilciuc S, Balo D, Harston G, Brzozowski K, Zięcina P, Narloch J, Wierzbicki M, Piasecki P.

Translational Stroke Research · Volume and issue year 2026
First published 2026-02-25 · PMID 41739286
DOI 10.1007/s12975-026-01414-z

Human Study2025REF. 02

What does the short-term stroke observation of the standard treatment adjuvant protocol indicate?

Research Findings

Adding Cerebrolysin was associated with improved nerve and daily ability scores at 14 days.[2] ↗

Study Design

Single-center prospective observation; acute ischemic stroke

Scope & Limitations

Short follow-up, non-randomized; clinical formulation and the 60mg powder on the website cannot be assumed to be the same.

View the Article Title and Full Citation+

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Kandasamy G, Arumugam V, Orayj K, Alshahrani AM, Alanazi TS, Hmlan A, Venugopal JP.

Medicina (Kaunas, Lithuania) · Volume/Issue Year 2025
First published 2025-08-26 · PMID 41010922
DOI 10.3390/medicina61091531

Human Study2025REF. 03

What findings are there in multinational stroke real-world comparisons?

Research Findings

Functional recovery indicators were better at 90 days in patients with moderate acute ischemic stroke.[3] ↗

Study Design

Multinational real-world stroke comparison; C-REGS2

Scope & Limitations

Observational comparison; cannot be considered a randomized trial.

View the Article Title and Full Citation+

C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.

Vosko MR, Sanak D, Do Y, Vatanagul JS, Roushdy T, Bornstein NM, Vester JC, Brainin M.

International Journal of Stroke: Official Journal of the International Stroke Society · Volume/Issue/Year 2025
First published 2025-08-24 · PMID 40851188
DOI 10.1177/17474930251375439

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Cerebrolysin · Frequently Asked Questions.

What research findings exist regarding Cerebrolysin in post-stroke neurological and functional rehabilitation?+

Adjunct Cerebrolysin associated with better 12-month functional independence. Additional research reports: adding Cerebrolysin associated with improvement in 14-day neurological and daily living ability scores.[1] ↗ [2] ↗

Can the clinical data of Cerebrolysin in mL match 60mg lyophilized product?+

cannot be automatically matched. Source, formulation, and activity correspondence information is required; the selected stroke studies also include observational designs, and correlation cannot be directly considered as causal efficacy.[1] ↗ [2] ↗ [3] ↗

Cerebrolysin—these conclusions apply to which study populations?+

Propensity-matched observational cohort of stroke thrombectomy patients; single-center prospective observation; acute ischemic stroke; multi-country real-world stroke comparison; C-REGS2. Selective population, no random allocation, residual confounding exists.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp